Furthermore, while mechanistic implications of BRCA1/2 in GC pathogenesis remain obscure, there is evidence that GC may be enriched for mutations in genes associated with HR and confer a tumor mutation signature associated with HR deficiency [29,30,31]. The gene discussed is BRCA1; the disease is neoplasm.